Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL21816612

CCN1CCNC[C@H]1C.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.36
DPP4 P27487 2/20 0.34
DPP8 Q6V1X1 2/20 0.34
DPP7 Q9UHL4 2/20 0.34
CHRM1 P11229 1/20 0.33
HRH4 Q9H3N8 3/20 0.32
DRD2 P14416 1/20 0.32
DRD1 P21728 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
SIGMAR1 Q99720 1/20 0.31
F2 P00734 1/20 0.31
F9 P00740 1/20 0.31
F10 P00742 1/20 0.31
F12 P00748 1/20 0.31
PRSS1 P07477 1/20 0.31
PRSS2 P07478 1/20 0.31
F7 P08709 1/20 0.31
PRSS3 P35030 1/20 0.31
HRH3 Q9Y5N1 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL21816610 1.00 PKM (0.36) PKMDPP4DPP8DPP7CHRM1
Trifluoroacetic Acid SCHEMBL28058921 0.88 DRD2 (0.40) PKMDPP4DPP8DPP7HRH4
Trifluoroacetic Acid SCHEMBL28320685 0.88 DRD2 (0.40) PKMDPP4DPP8DPP7HRH4
Trifluoroacetic Acid SCHEMBL28058912 0.86 PKM (0.36) PKMDPP4DPP8DPP7HRH4
Trifluoroacetic Acid SCHEMBL28719832 0.86 PKM (0.36) PKMDPP4DPP8DPP7HRH4
Trifluoroacetic Acid SCHEMBL28321793 0.86 PKM (0.36) PKMDPP4DPP8DPP7HRH4
Trifluoroacetic Acid SCHEMBL28721572 0.84 PKM (0.34) PKMDPP4DPP8DPP7HRH4
Trifluoroacetic Acid SCHEMBL28721929 0.83 PKM (0.36) PKMDPP4DPP8DPP7HRH4
Trifluoroacetic Acid SCHEMBL29568202 0.83 PKM (0.36) PKMDPP4DPP8DPP7HRH4
Trifluoroacetic Acid SCHEMBL28320679 0.83 PKM (0.36) PKMDPP4DPP8DPP7HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3640248-B1 AMINOPYRIMIDINE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF BEIJING ADAMADLE BIOTECHNOLOGY LLC (CN) 2023-08-23 EP disclosed
US-11352352-B2 Aminopyrimidine compound, preparation method therefor and use thereof Beijing Adamadle Biotechnology Limited Liability Company (CN) 2022-06-07 US disclosed
CN-108707139-B Aminopyrimidine compound and preparation method and application thereof 北京鞍石生物科技有限责任公司 2021-04-06 CN disclosed
EP-3640248-A1 AMINOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Beijing Adamadle Biotechnology Limited Liability Company (CN) 2020-04-22 EP disclosed
US-20200087296-A1 AMINOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Beijing Adamadle Biotechnology Limited Liability Company (CN) 2020-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200087296-A1 AMINOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF WEE1, WEE2, EGFR PKM 1079/4885DPP4 1161/4885DPP8 525/4885
US-11352352-B2 Aminopyrimidine compound, preparation method therefor and use thereof WEE1, WEE2, EGFR PKM 1079/4885DPP4 1161/4885DPP8 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.